BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mitchell R, McDermid J, Ma MM, Chik CL. MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol 2011; 3(6): 157-163 [PMID: 21860675 DOI: 10.4254/wjh.v3.i6.157]
URL: https://www.wjgnet.com/1948-5182/full/v3/i6/157.htm
Number Citing Articles
1
Jelena Jadzic, Danijela Djonic. Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?World Journal of Gastroenterology 2023; 29(5): 825-833 doi: 10.3748/wjg.v29.i5.825
2
Andreas K. Nussler, Britt Wildemann, Thomas Freude, Christian Litzka, Petra Soldo, Helmut Friess, Seddik Hammad, Jan G. Hengstler, Karl F. Braun, Viviane Trak-Smayra, Patricio Godoy, Sabrina Ehnert. Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver–bone axisArchives of Toxicology 2014; 88(4): 997 doi: 10.1007/s00204-013-1191-5
3
Jelena Jadzic, Petar D. Milovanovic, Danica Cvetkovic, Vladimir Zivkovic, Slobodan Nikolic, Nada Tomanovic, Marija P. Djuric, Danijela Djonic. The altered osteocytic expression of connexin 43 and sclerostin in human cadaveric donors with alcoholic liver cirrhosis: Potential treatment targetsJournal of Anatomy 2022; 240(6): 1162 doi: 10.1111/joa.13621
4
Qiu-Bo Zhang, Yin-Ting Chen, Guo-Da Lian, Chen-Chen Qian, Shao-Jie Chen, Kai-Hong Huang. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosisClinics and Research in Hepatology and Gastroenterology 2012; 36(6): 583 doi: 10.1016/j.clinre.2012.04.014
5
Astushi Nakamura, Tsubasa Yoshimura, Shunsuke Nagata, Manami Deguchi, Yuei Hosokawa, Go Someya, Takeshi Ichikawa, Keiji Okuyama, Yosihiro Yosioka, Hitoshi Asakura, Kenji Ogawa. Bone mass reductions in patients with chronic liver disease: the significance of bone mineral density measurements of vertebral bones using abdominal computed tomographyKanzo 2019; 60(11): 414 doi: 10.2957/kanzo.60.414
6
Preyander Thakur, Kripa Elizabeth Cherian, Nitin Kapoor, Grace Rebekah, Ashish Goel, Uday Zachariah, C.E. Eapen, Nihal Thomas, Thomas V. Paul. Proximal Hip Geometry, Trabecular Bone Score, Bone Mineral Density and Bone Mineral Parameters in Patients With Cryptogenic and Hepatitis B Related Cirrhosis- A Study From the Indian SubcontinentJournal of Clinical Densitometry 2022; 25(1): 97 doi: 10.1016/j.jocd.2021.03.001
7
Zhongbo Liu, Tianzhen Han, Haim Werner, Clifford J Rosen, Mitchell B Schaffler, Shoshana Yakar. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone MassJournal of Bone and Mineral Research 2018; 33(1): 123 doi: 10.1002/jbmr.3290
8
Ana Monegal, Miquel Navasa, Pilar Peris, Jordi Colmenero, Andrea Cuervo, África Muxí, Laia Gifre, Núria Guañabens. Bone Disease in Patients Awaiting Liver Transplantation. Has the Situation Improved in the Last Two Decades?Calcified Tissue International 2013; 93(6): 571 doi: 10.1007/s00223-013-9797-4
9
Ahmed O. Kaseb, Lianchun Xiao, Manal M. Hassan, Young Kwang Chae, Ju-Seog Lee, Jean-Nicolas Vauthey, Sunil Krishnan, Sheree Cheung, Hesham M. Hassabo, Thomas Aloia, Claudius Conrad, Steven A. Curley, John M. Vierling, Prasun Jalal, Kanwal Raghav, Michael Wallace, Asif Rashid, James L. Abbruzzese, Robert A. Wolff, Jeffrey S. Morris. Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular CarcinomaJNCI: Journal of the National Cancer Institute 2014; 106(5) doi: 10.1093/jnci/dju088
10
Jelena Jadžić, Danijela Đonić. Compromised bone strength in patients with alcoholic liver cirrhosisMedicinski podmladak 2020; 71(4): 27 doi: 10.5937/mp71-27443